trial · primary record
Nemtabrutinib
Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2029-10-20 |
| Primary endpoint | Complete response (CR) |
| Registry ID | NCT07194980 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:07.763Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07194980
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nemtabrutinib · compound